Skip to main content
. 2022 Feb 22;12:3025. doi: 10.1038/s41598-022-07098-3

Figure 2.

Figure 2

Kaplan–Meier survival curves of overall survival (OS) and relapse-free survival (RFS) according to WBCmax in patients with stage II/III gastric cancer. (A) The five-year OS rates were 58.1% in the low-WBCmax group and 37.4% in the high-WBCmax group (p < 0.001). (B) The five-year RFS rate were 56.1% in the low-WBCmax group and 36.1% in the high-WBCmax group (p = 0.001).